Chimeric antigen receptor with novel intracellular modules improves antitumor performance of T cells
{{output}}
The excessive cytokine release and limited persistence represent major challenges for chimeric antigen receptor T (CAR-T) cell therapy in diverse tumors. Conventional CARs employ an intracellular domain (ICD) from the ζ subunit of CD3 as a signaling module, a... ...
